Though they remain a leading killer, heart attacks can be effectively treated in the event they can be rapidly diagnosed next initial onset of symptoms. In a study appearing in this month's Molecular and Cellular Proteomics, researchers have identified cardiac myosin-binding protein C (cMyBP-C) as a inherent new diagnostic biomarker for heart attacks, one that may be particularly high-priced for mild attacks in which established diagnostic proteins may not be copious enough.

More: - Brought to my attention by